Skip to main content

Day: March 10, 2023

SpringServe joins the Amazon Publisher Services Streaming TV Ad Server Certification Program

NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) — SpringServe, the leading independent ad serving platform now part of Magnite (NASDAQ:MGNI), announced today that it will be joining the Amazon Publisher Services (APS) Ad Server Certification Program for streaming TV. SpringServe’s certification with APS will allow publishers to implement a simplified APS header bidding integration while maximizing the benefits of programmatic monetization across their streaming TV endpoints. Header bidding allows publishers to conduct a unified auction across all advertiser bids to help improve the viewer experience by limiting repeat ads as well as increase monetization for publishers’ ad inventory. “APS’ header bidding technology helps media owners improve the viewer experience by reducing latency and preventing repeat ads, which is important in a...

Continue reading

ProSomnus® Announces Acceptance of Abstract at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference

PLEASANTON, Calif., March 10, 2023 (GLOBE NEWSWIRE) — ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that an abstract showcasing data from a study comparing the efficacy of Precision Oral Appliance Therapy (OAT) and traditional OAT has been accepted for a Thematic Poster Session at the European Respiratory Society (ERS) and European Sleep Research Society’s (ESRS) Sleep and Breathing 2023 Conference, being held from April 20-22 in Prague, Czech Republic. Dr. Shouresh Charkhandeh, BMedSc, DDS, is scheduled to present the data in a session titled, “Pharmacological and non-pharmacological treatment and lifestyle interventions in sleep disordered breathing,” on Thursday, April 20 at 2:00 p.m. Central European Time/8:00 a.m. Eastern...

Continue reading

Solar Integrated Roofing Corp. to Participate in the 35th Annual ROTH Conference

HENDERSON, Nev., March 10, 2023 (GLOBE NEWSWIRE) — Solar Integrated Roofing Corp. (OTC:SIRC) (“SIRC” or the Company”), an integrated, single-source solutions provider of solar power, roofing and EV charging systems, will participate in the 35th Annual ROTH Conference that will be held March 12-14, 2023 at The Ritz Carlton in Dana Point, California. SIRC Chief Executive Officer David Massey will attend the event in-person where he will participate in one-on-one meetings to discuss the Company’s recent and upcoming key milestones. 35th Annual ROTH Conference Date: March 12-14, 2023Format: In-person one-on-one meetingsConference Website: Click here For more information on the 35th Annual ROTH Conference, please contact your ROTH representative or you may also email your request to SIRC@mzgroup.us. About Solar Integrated Roofing Corp. Solar...

Continue reading

FOREWARN Partners with San Antonio Board of REALTORS®

Texas-based Association contracts to make FOREWARN services available for its 13,000+ real estate professional members to promote proactive agent safety BOCA RATON, Fla., March 10, 2023 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that San Antonio Board of REALTORS® (“SABOR”) has contracted to make FOREWARN® services available for the 13,000+ members they serve throughout San Antonio and the surrounding area to promote proactive real estate agent safety. Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information provided by potential...

Continue reading

Rovio Entertainment Corp.: Notice to the Annual General Meeting of Rovio Entertainment Corporation

Rovio Entertainment Corporation      Stock Exchange Release        March 10, 2023 at 3.00 p.m. EET Notice to the Annual General Meeting of Rovio Entertainment Corporation Notice is given to the shareholders of Rovio Entertainment Corporation (the “Company”) of the Annual General Meeting to be held on Monday, April 3, 2023 at 1:00 p.m. (Finnish time) at Hanaholmen, Hanasaarenranta 5, FI-02100 Espoo. The reception of persons who have registered for the Annual General Meeting and the distribution of voting tickets will commence at the venue at 12:00 noon. Coffee will be served at the venue before the meeting starting at 12:00 noon. A. MATTERS ON THE AGENDA OF THE ANNUAL GENERAL MEETING 1. Opening of the Meeting 2. Calling the Meeting to order 3. Election of persons to scrutinize the minutes and to supervise the counting of votes 4....

Continue reading

Nuvectis Pharma to Participate in a Fireside Chat at the 35th Annual Roth Conference

FORT LEE, NJ, March 10, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will participate in a fireside chat at the 35th Annual Roth Conference.Event 35th Annual Roth ConferenceDate March 14, 2023Time 12:00 PM Pacific Time (3:00 PM Eastern Time)Format Fireside ChatLink https://wsw.com/webcast/roth46/nvct/1849405About Nuvectis Pharma Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. The Company is currently...

Continue reading

Ferrellgas Partners, L.P. Reports Second Quarter Fiscal 2023 Results

Financial HighlightsRevenues for the second fiscal quarter were flat with a slight decrease of $1.0 million compared to the prior year period. Gross Profit for the second fiscal quarter increased $34.0 million, or 11%, compared to the prior year period. Margin per gallon for the second fiscal quarter increased $0.13, or 12%, compared to the prior year period. Net earnings attributable to Ferrellgas Partners, L.P. decreased $10.3 million, or 10%, compared to the prior year period. Adjusted EBITDA increased by $4.5 million, or 3%, compared to the prior year period.Company HighlightsFerrellgas welcomed Rez-Bear Propane, located in Harris, New York, as its newest acquisition to the Ferrellgas Family during the second fiscal quarter. Blue Rhino became the official propane sponsor of the Steak Cookoff Association for 2023. In the second...

Continue reading

Hurco Reports First Quarter Results For Fiscal Year 2023 and Announces Quarterly Cash Dividend

INDIANAPOLIS, March 10, 2023 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the first fiscal quarter ended January 31, 2023. Hurco recorded net income of $1,330,000, or $0.20 per diluted share, for the first quarter of fiscal year 2023, compared to net income of $3,535,000, or $0.53 per diluted share, for the corresponding period in fiscal year 2022. Sales and service fees for the first quarter of fiscal year 2023 were $54,682,000, a decrease of $12,205,000, or 18%, compared to the corresponding prior year period, and included an unfavorable currency impact of $3,189,000, or 5%, when translating foreign sales to U.S. dollars for financial reporting purposes. Greg Volovic, Chief Executive Officer, stated, “Right now the global machine tool market is experiencing some oscillation in demand that...

Continue reading

89bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

– Topline results from ENLIVEN Phase 2b NASH trial on track for first quarter of 2023 – – Feedback from FDA supports advancement of Phase 3 program for pegozafermin in SHTG; plan to initiate first of two SHTG Phase 3 trials in the second quarter of 2023 – – Published results of Phase 1b/2a study of pegozafermin for the treatment of NASH in The Lancet Gastroenterology & Hepatology – SAN FRANCISCO, March 10, 2023 (GLOBE NEWSWIRE) —  89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today reported its financial results for the fourth quarter and full year ended December 31, 2022. “In 2022, we made significant advancements across our late-stage clinical development program for...

Continue reading

Longeveron Inc. Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

— Full results from ELPIS I trial published in European Heart Journal Open –         — First patient to be randomized in Japan Aging-Related Phase 2 study in Q1 – — Conference call scheduled for 8:30 a.m. ET today — MIAMI, March 10, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today provided a business update and reported its financial results for the fourth quarter and full year of 2022. “Longeveron had a productive 2022, executing on multiple key milestones as we continued to advance Lomecel-BTM for multiple indications,” said Wa’el Hashad, Chief Executive Officer. “Earlier this year, the full data from our ELPIS I trial of Lomecel-BTM for infants...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.